Clinical Trials
2 trialsNCT01995188 2017-10-04
A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer
Genentech, Inc.
Phase 1 Completed
NCT01363947 2017-06-07
Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer
Genentech, Inc.
Phase 1 Completed